Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.08 EUR
−83.53 M EUR
5.61 M EUR
860.23 M
About MESOBLAST LIMITED
Sector
Industry
CEO
Silviu Itescu
Website
Headquarters
Melbourne
Founded
2004
ISIN
AU000000MSB8
FIGI
BBG000QP42Y9
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LWB is 1.03 EUR — it has increased by 1.98% in the past 24 hours. Watch MESOBLAST LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MESOBLAST LTD stocks are traded under the ticker LWB.
LWB stock has risen by 10.16% compared to the previous week, the month change is a 30.38% rise, over the last year MESOBLAST LTD has showed a 325.62% increase.
We've gathered analysts' opinions on MESOBLAST LTD future price: according to them, LWB price has a max estimate of 1.73 EUR and a min estimate of 0.72 EUR. Watch LWB chart and read a more detailed MESOBLAST LTD stock forecast: see what analysts think of MESOBLAST LTD and suggest that you do with its stocks.
LWB stock is 1.94% volatile and has beta coefficient of −0.34. Track MESOBLAST LTD stock price on the chart and check out the list of the most volatile stocks — is MESOBLAST LTD there?
Today MESOBLAST LTD has the market capitalization of 1.20 B, it has decreased by −4.05% over the last week.
Yes, you can track MESOBLAST LTD financials in yearly and quarterly reports right on TradingView.
MESOBLAST LTD is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
LWB earnings for the last half-year are −0.05 EUR per share, whereas the estimation was −0.03 EUR, resulting in a −41.64% surprise. The estimated earnings for the next half-year are −0.04 EUR per share. See more details about MESOBLAST LTD earnings.
MESOBLAST LTD revenue for the last half-year amounts to 2.34 M EUR, despite the estimated figure of 3.82 M EUR. In the next half-year revenue is expected to reach 2.79 M EUR.
LWB net income for the last half-year is −52.40 M EUR, while the previous report showed −30.76 M EUR of net income which accounts for −70.36% change. Track more MESOBLAST LTD financial stats to get the full picture.
No, LWB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 73.00 employees. See our rating of the largest employees — is MESOBLAST LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MESOBLAST LTD EBITDA is −51.42 M EUR, and current EBITDA margin is −917.74%. See more stats in MESOBLAST LTD financial statements.
Like other stocks, LWB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MESOBLAST LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MESOBLAST LTD technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MESOBLAST LTD stock shows the buy signal. See more of MESOBLAST LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.